Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

समान संसाधन

• Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
  द्वारा: Iwanami, Akira, और अन्य
  प्रकाशित: (2020)
• Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study
  द्वारा: Naya, Noriyuki, और अन्य
  प्रकाशित: (2020)
• Long‐term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention‐deficit/hyperactivity disorder
  द्वारा: Ichikawa, Hironobu, और अन्य
  प्रकाशित: (2019)
• Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
  द्वारा: Ichikawa, Hironobu, और अन्य
  प्रकाशित: (2020)
• Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
  द्वारा: Martinez-Raga, Jose, और अन्य
  प्रकाशित: (2015)